4//SEC Filing
O'Byrne Jason 4
Accession 0001209191-22-007860
CIK 0001619856other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 7:27 PM ET
Size
7.2 KB
Accession
0001209191-22-007860
Insider Transaction Report
Form 4
O'Byrne Jason
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-02-08$4.11/sh+24,336$100,021→ 24,336 total - Exercise/Conversion
Option to purchase Common Stock
2022-02-08−24,336→ 412,865 totalExercise: $4.11Exp: 2031-03-29→ Common Stock (24,336 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to this option vested on February 8, 2022 and an additional 1/48th of the aggregate number of shares subject to the option will vest on the corresponding day of each month thereafter until the option is fully vested on February 8, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.
Documents
Issuer
Caribou Biosciences, Inc.
CIK 0001619856
Entity typeother
Related Parties
1- filerCIK 0001871145
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 7:27 PM ET
- Size
- 7.2 KB